Article info
PDFHepatology
Original research
Epigenetic mechanisms and metabolic reprogramming in fibrogenesis: dual targeting of G9a and DNMT1 for the inhibition of liver fibrosis
- Correspondence to Professor Matias A Avila, Hepatology, CIMA-University of Navarra, Pamplona, Spain; maavila{at}unav.es; Dr Maite G Fernandez-Barrena, Hepatology, CIMA-University of Navarra, Pamplona, Spain; magarfer{at}unav.es
Citation
Epigenetic mechanisms and metabolic reprogramming in fibrogenesis: dual targeting of G9a and DNMT1 for the inhibition of liver fibrosis
Publication history
- Received October 31, 2019
- Revised March 16, 2020
- Accepted March 29, 2020
- First published April 23, 2020.
Online issue publication
January 07, 2021
Article Versions
- Previous version (23 April 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.